Literature DB >> 7192183

Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.

M J Mirro, A S Manalan, J C Bailey, A M Watanabe.   

Abstract

We studied the interaction of disopyramide, quinidine, and procainamide with cardiac muscarinic receptors. In electrophysiological experiments, the effects of disopyramide, quinidine, procainamide, and atropine were determined on spontaneously depolarizing guinea pig right atria (GPRA) both in the presence and absence of pharmacologically induced (physostigmine) cholinergic stimulation. All four agents demonstrated a concentration-dependent antagonism of the negative chronotropic effects of physostigmine. The order of anticholinergic potency was atropine greater than disopyramide greater than quinidine greater than procainamide. The ability of disopyramide to antagonize the physostigmine induced slowing was stereoselective, (+)disopyramide greater than (-)disopyramide. In contrast, the ability of quinidine to antagonize the negative chronotropic effects of physostigmine was non-stereoselective, quinidine = quinine. In parallel experiments, we studied the ability of disopyramide, quinidine, procainamide, and atropine to compete with the radiolabeled muscarinic receptor antagonist [3H] quinuclidinyl benzilate ([3H]QNB) for binding to muscarinic receptors in crude homogenates of GPRA and membrane vesicles from canine ventricular myocardium. All four agents inhibited [3H]QNB binding to muscarinic receptors. The order of anticholinergic potency determined by the receptor binding studies was identical to that determined by the physiological studies. The interaction of disopyramide with muscarinic receptors was stereoselective, (+)disopyramide > (-)disopyramide. Quinidine was only slightly more potent than quinine in inhibiting [3H]QNB binding to muscarinic receptors. Interaction of antiarrhythmic drugs with muscarinic receptors satisfied criteria for a competitive interaction. The data from this study localize the anticholinergic effects of disopyramide and quinidine to the muscarinic receptor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192183     DOI: 10.1161/01.res.47.6.855

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Anticholinergic action of quinidine sulfate in the rabbit atrioventricular node.

Authors:  M Nishimura; R M Huan; Y Habuchi; N Homma; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  Antimuscarinic action of quinidine on the heart? A study in myocardial preparations from cat hearts.

Authors:  H Nawrath; U Sack; X Zong
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

4.  Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.

Authors:  E Burgisser; A De Lean; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug.

Authors:  T J Campbell; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

6.  Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man.

Authors:  J Hasselström; M Enquist; J Hermansson; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.

Authors:  J K Campbell; R J Marshall; E Winslow
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

8.  Comparison of the parasympatholytic activity of ACC-9358 and disopyramide.

Authors:  B S Brown; R J Gorczynski; R D Reynolds; J E Shaffer
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

9.  Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.

Authors:  F Vanhoutte; J Vereecke; E Carmeliet; N Verbeke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

Review 10.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.